{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:12:27Z","timestamp":1778836347120,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["CAN2023 \/2919"],"award-info":[{"award-number":["CAN2023 \/2919"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","award":["987911"],"award-info":[{"award-number":["987911"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007230","name":"Foundation King Gustaf V Jubilee Fund","doi-asserted-by":"publisher","award":["204053"],"award-info":[{"award-number":["204053"]}],"id":[{"id":"10.13039\/501100007230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007231","name":"Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007075","name":"European Society for Medical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007232","name":"Cancer Research Foundations of Radiumhemmet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010355","name":"Hellenic Society of Medical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010355","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016669","name":"Sj\u00f6berg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004429","name":"University of Crete","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.esmoop.2025.106028","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T13:26:37Z","timestamp":1767360397000},"page":"106028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Irradiated tumor volume as a predictor of local recurrence and radionecrosis in lung cancer with brain metastases treated with stereotactic radiosurgery"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2334-444X","authenticated-orcid":false,"given":"A.","family":"Koulouris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Grundberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8692-6426","authenticated-orcid":false,"given":"M.","family":"Skribek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9737-5367","authenticated-orcid":false,"given":"C.","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hydbring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gubanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ekman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4397-7391","authenticated-orcid":false,"given":"G.","family":"Tsakonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.esmoop.2025.106028_bib1","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2025.106028_bib2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2025.106028_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108436","article-title":"Brain metastases and mortality in patients with ALK + metastatic non-small cell lung cancer treated with second-generation ALK tyrosine kinase inhibitors as first-line targeted therapies: an observational cohort study","volume":"201","author":"Uprety","year":"2025","journal-title":"Lung Cancer"},{"issue":"7","key":"10.1016\/j.esmoop.2025.106028_bib4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.23.02219","article-title":"CNS efficacy of osimertinib with or without chemotherapy in epidermal growth factor receptor-mutated advanced non-small-cell lung cancer","volume":"42","author":"J\u00e4nne","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2025.106028_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fonc.2018.00088","article-title":"Brain metastases in oncogene-addicted non-small cell lung cancer patients: incidence and treatment","volume":"8","author":"Remon","year":"2018","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2025.106028_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.esmoop.2025.106028_bib7","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/ijc.34628","article-title":"Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasis","volume":"153","author":"Tsakonas","year":"2023","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2025.106028_bib8","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3390\/cancers14051240","article-title":"Oncologic outcome and immune responses of radiotherapy with anti-PD-1 treatment for brain metastases regarding timing and benefiting subgroups","volume":"14","author":"Trommer","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.esmoop.2025.106028_bib9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijrobp.2016.06.006","article-title":"The effect of gene alterations and tyrosine kinase inhibition on survival and cause of death in patients with adenocarcinoma of the lung and brain metastases","volume":"96","author":"Sperduto","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.esmoop.2025.106028_bib10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ijrobp.2014.10.024","article-title":"Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis","volume":"91","author":"Sahgal","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.esmoop.2025.106028_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.lungcan.2021.02.036","article-title":"Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancer","volume":"155","author":"Moraes","year":"2021","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.esmoop.2025.106028_bib12","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3171\/2022.9.JNS221896","article-title":"Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy alone","volume":"138","author":"Dohm","year":"2022","journal-title":"J Neurosurg"},{"key":"10.1016\/j.esmoop.2025.106028_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103431","article-title":"Role of stereotactic radiosurgery for the treatment of brain metastasis in the era of immunotherapy: a systematic review on current evidences and predicting factors","volume":"165","author":"Gagliardi","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"10.1016\/j.esmoop.2025.106028_bib14","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/neuonc\/noab129","article-title":"Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO","volume":"23","author":"Scoccianti","year":"2021","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2025.106028_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/00207454.2021.1900843","article-title":"Radionecrosis (RN) in patients with brain metastases treated with stereotactic radiosurgery (SRS) and immunotherapy","volume":"133","author":"Andring","year":"2023","journal-title":"Int J Neurosci"},{"issue":"1","key":"10.1016\/j.esmoop.2025.106028_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2022.03.020","volume":"114","author":"Sperduto","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.esmoop.2025.106028_bib17","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1038\/s41598-018-20622-8","article-title":"Contraction of T cell richness in lung cancer brain metastases","volume":"8","author":"Mansfield","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.esmoop.2025.106028_bib18","article-title":"Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy","volume":"14","author":"Sereno","year":"2023","journal-title":"Front Immunol"},{"issue":"13","key":"10.1016\/j.esmoop.2025.106028_bib19","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.3390\/cancers13133151","article-title":"High density of NRF2 expression in malignant cells is associated with increased risk of CNS metastasis in early-stage NSCLC","volume":"13","author":"Tsakonas","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.esmoop.2025.106028_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/ijms24010193","article-title":"Matched analyses of brain metastases versus primary non-small cell lung cancer reveal a unique microRNA signature","volume":"24","author":"Tsakonas","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.esmoop.2025.106028_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","article-title":"Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases","volume":"30","author":"Sperduto","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2025.106028_bib22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","article-title":"Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA)","volume":"3","author":"Sperduto","year":"2017","journal-title":"JAMA Oncol"},{"issue":"Pt B","key":"10.1016\/j.esmoop.2025.106028_bib23","article-title":"The stereotactic radiosurgery-brain prognostic index (SRS-BPI): a novel prognostic index for SRS-eligible lung cancer patients with brain metastases","volume":"196","author":"Koulouris","year":"2025","journal-title":"Comput Biol Med"},{"issue":"2","key":"10.1016\/j.esmoop.2025.106028_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/neuonc\/noy159","article-title":"Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose","volume":"21","author":"Moraes","year":"2019","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2025.106028_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10585-020-10037-z","article-title":"Cumulative intracranial tumour volume prognostic assessment: a new predicting score index for patients with brain metastases treated by stereotactic radiosurgery","volume":"37","author":"Donofrio","year":"2020","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.esmoop.2025.106028_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.wneu.2017.07.109","article-title":"Improving the prognostic value of disease-specific graded prognostic assessment model for renal cell carcinoma by incorporation of cumulative intracranial tumor volume","volume":"108","author":"Ali","year":"2017","journal-title":"World Neurosurg"},{"issue":"Suppl 2","key":"10.1016\/j.esmoop.2025.106028_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3171\/2014.8.GKS141421","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors","volume":"121","author":"Yamamoto","year":"2014","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.esmoop.2025.106028_bib28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ijrobp.2013.03.037","article-title":"Multidose stereotactic radiosurgery (9 Gy x 3) of the postoperative resection cavity for treatment of large brain metastases","volume":"86","author":"Minniti","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.esmoop.2025.106028_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijrobp.2020.10.034","article-title":"Tumor control probability of radiosurgery and fractionated stereotactic radiosurgery for brain metastases","volume":"110","author":"Redmond","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.esmoop.2025.106028_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11060-015-1881-3","article-title":"Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases","volume":"125","author":"Kohutek","year":"2015","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.esmoop.2025.106028_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijrobp.2020.06.057","article-title":"Predictors of adverse radiation effect in brain metastasis patients treated with stereotactic radiosurgery and immune checkpoint inhibitor therapy","volume":"108","author":"Helis","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"20","key":"10.1016\/j.esmoop.2025.106028_bib32","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.3390\/cancers15205092","article-title":"Radiosurgery for brain metastases: challenges in imaging interpretation after treatment","volume":"15","author":"Romano","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.esmoop.2025.106028_bib33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/neuonc\/nov301","article-title":"A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation","volume":"18","author":"Hatzoglou","year":"2016","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2025.106028_bib34","first-page":"281","article-title":"Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy","volume":"19","author":"Ceccon","year":"2017","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2025.106028_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12149-017-1227-7","article-title":"Diagnostic accuracy of (11)C-methionine PET in detecting neuropathologically confirmed recurrent brain tumor after radiation therapy","volume":"32","author":"Kits","year":"2018","journal-title":"Ann Nucl Med"},{"issue":"6","key":"10.1016\/j.esmoop.2025.106028_bib36","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","article-title":"Response assessment criteria for brain metastases: proposal from the RANO group","volume":"16","author":"Lin","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmoop.2025.106028_bib37","first-page":"1","article-title":"Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: evaluation of predictive factors","volume":"36","author":"Leyrat","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.esmoop.2025.106028_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/sni.sni_303_18","article-title":"Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases","volume":"10","author":"Peng","year":"2019","journal-title":"Surg Neurol Int"},{"issue":"2","key":"10.1016\/j.esmoop.2025.106028_bib39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijrobp.2013.07.022","article-title":"The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?","volume":"88","author":"Brown","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.esmoop.2025.106028_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11060-012-0881-9","article-title":"Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery","volume":"109","author":"Stockham","year":"2012","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.esmoop.2025.106028_bib41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12885-023-10761-1","article-title":"SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases","volume":"23","author":"Crouzen","year":"2023","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.esmoop.2025.106028_bib42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.prro.2022.02.003","article-title":"Radiation therapy for brain metastases: an ASTRO clinical practice guideline","volume":"12","author":"Gondi","year":"2022","journal-title":"Pract Radiat Oncol"},{"issue":"20","key":"10.1016\/j.esmoop.2025.106028_bib43","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1200\/JCO.22.00333","article-title":"Radiation therapy for brain metastases: ASCO guideline endorsement of ASTRO guideline","volume":"40","author":"Schiff","year":"2022","journal-title":"J Clin Oncol"},{"issue":"10055","key":"10.1016\/j.esmoop.2025.106028_bib44","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0140-6736(16)30825-X","volume":"388","author":"Mulvenna","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.esmoop.2025.106028_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109744","article-title":"Stereotactic radiosurgery versus whole-brain radiotherapy in patients with 4-10 brain metastases: a nonrandomized controlled trial","volume":"186","author":"Bodensohn","year":"2023","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2025.106028_bib46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","article-title":"Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain","volume":"110","author":"Milano","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.esmoop.2025.106028_bib47","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijrobp.2018.02.175","article-title":"Improved overall survival and locoregional disease control with concurrent PD-1 pathway inhibitors and stereotactic radiosurgery for lung cancer patients with brain metastases","volume":"101","author":"Schapira","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.esmoop.2025.106028_bib48","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1080\/02688697.2021.2022098","article-title":"Stereotactic radiosurgery with immune checkpoint inhibitors for brain metastases: a meta-analysis study","volume":"37","author":"Badrigilan","year":"2023","journal-title":"Br J Neurosurg"},{"issue":"8","key":"10.1016\/j.esmoop.2025.106028_bib49","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jamaoncol.2017.3993","article-title":"Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation","volume":"4","author":"Martin","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.esmoop.2025.106028_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102923","article-title":"Brain metastasis formation and irradiation by stereotactic radiation therapy combined with immunotherapy: a systematic review","volume":"149","author":"Pin","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.esmoop.2025.106028_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54513-3","article-title":"Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases","volume":"9","author":"Ascha","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.esmoop.2025.106028_bib52","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/COC.0b013e31829c3139","article-title":"Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience","volume":"38","author":"Sadraei","year":"2015","journal-title":"Am J Clin Oncol"},{"issue":"9","key":"10.1016\/j.esmoop.2025.106028_bib53","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/neuonc\/not085","article-title":"Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery","volume":"15","author":"Boothe","year":"2013","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2025.106028_bib54","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/cancers16071249","article-title":"Intracranial efficacy of atezolizumab, bevacizumab, carboplatin, and paclitaxel in real-world patients with non-small-cell lung cancer and EGFR or ALK alterations","volume":"16","author":"Rathbone","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.esmoop.2025.106028_bib55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/brainsci14040321","article-title":"Evaluating the efficacy of perfusion MRI and conventional MRI in distinguishing recurrent cerebral metastasis from brain radiation necrosis","volume":"14","author":"Schack","year":"2024","journal-title":"Brain Sci"},{"issue":"1","key":"10.1016\/j.esmoop.2025.106028_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25389-7","article-title":"Performance sensitivity analysis of brain metastasis stereotactic radiosurgery outcome prediction using MRI radiomics","volume":"12","author":"DeVries","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.esmoop.2025.106028_bib57","article-title":"Prediction of treatment response after stereotactic radiosurgery of brain metastasis using deep learning and radiomics on longitudinal MRI data","volume":"14","author":"Cho","year":"2024","journal-title":"Sci Rep"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925018988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925018988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:49:50Z","timestamp":1778834990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702925018988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2059702925018988"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.106028","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Irradiated tumor volume as a predictor of local recurrence and radionecrosis in lung cancer with brain metastases treated with stereotactic radiosurgery","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.106028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"106028"}}